You are here:

Archived: racecadotril (Hidrasec Infants, Hidrasec Children)

Advice

Following a full submission:

racecadotril (Hidrasec Infants®, Hidrasec Children®) is not recommended for use within NHS Scotland.

Indication under review: Complementary symptomatic treatment of acute diarrhoea in infants older than three months and in children, together with oral rehydration and the usual support measures, when these measures alone are insufficient to control the clinical condition.

Racecadotril was significantly better than placebo in reducing mean stool output at 48 hours in children with acute diarrhoea treated in hospital. There is insufficient evidence that it improves recovery rate.

The submitting company did not present a sufficiently robust clinical and economic analysis to gain acceptance by SMC. 

Drug Details

Drug Name: racecadotril (Hidrasec Infants, Hidrasec Children)
SMC Drug ID: 818/12
Manufacturer: Abbott Laboratories Limited
Indication: Complementary symptomatic treatment of acute diarrhoea in infants (older than 3 months) and children, together with oral rehydration, and the usual support measures, when these measures alone are insufficient to control the clinical condition. In adults it is indicated for the symptomatic treatment of acute diarrhoea.
BNF Category:
Submission Type: Full submission
Status: Not Recommended
Date Advice Published: 10 December 2012

Current Advice

Resubmission 11 August 2014

Back